| Dr Rodney Edwin Shackelford, DO | |
|
2451 University Hospital Dr, Mobile, AL 36617-2300 | |
| (251) 471-7790 | |
| (251) 471-7096 |
| Full Name | Dr Rodney Edwin Shackelford |
|---|---|
| Gender | Male |
| Speciality | Pathology - Molecular Genetic Pathology |
| Location | 2451 University Hospital Dr, Mobile, Alabama |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124227715 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0007X | Pathology - Molecular Genetic Pathology | DO.000021 (Louisiana) | Secondary |
| Entity Name | Louisiana State University Health Sciences Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417992249 PECOS PAC ID: 6103730908 Enrollment ID: O20031208000275 |
News Archive
Researchers at the University of Kentucky's College of Medicine have found that a class of antibiotics called aminoglycosides could be a promising treatment for frontotemporal dementia.
Obese men with prostate cancer are at higher risk for treatment failure after primary radiation therapy, according to a new study.
An Indiana University cancer researcher and her colleagues have identified genetic markers that may help determine who benefits from regular use of aspirin and other nonsteroidal anti-inflammatory drugs for lowering one's risk of developing colorectal cancer.
Cochlear Limited, the global leader in implantable hearing solutions, announced that the US Food and Drug Administration cleared the Cochlear Baha 4 Attract System for use in the United States. Cochlear is the only company to now offer patients a choice of either a magnetic or a direct bone conduction hearing solution.
Precision cancer medicine - diagnosis and treatment based on the genetic abnormalities of a specific tumor - is playing an ever-larger role in cancer care. The field got a boost earlier this year when President Barack Obama proposed a $215 million federal Precision Medicine Initiative with cancer as one of its priorities.
› Verified 8 days ago
| Entity Name | Lsu Health Sciences Center Shreveport Faculty Group Practice |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013374222 PECOS PAC ID: 4082902721 Enrollment ID: O20161012000307 |
News Archive
Researchers at the University of Kentucky's College of Medicine have found that a class of antibiotics called aminoglycosides could be a promising treatment for frontotemporal dementia.
Obese men with prostate cancer are at higher risk for treatment failure after primary radiation therapy, according to a new study.
An Indiana University cancer researcher and her colleagues have identified genetic markers that may help determine who benefits from regular use of aspirin and other nonsteroidal anti-inflammatory drugs for lowering one's risk of developing colorectal cancer.
Cochlear Limited, the global leader in implantable hearing solutions, announced that the US Food and Drug Administration cleared the Cochlear Baha 4 Attract System for use in the United States. Cochlear is the only company to now offer patients a choice of either a magnetic or a direct bone conduction hearing solution.
Precision cancer medicine - diagnosis and treatment based on the genetic abnormalities of a specific tumor - is playing an ever-larger role in cancer care. The field got a boost earlier this year when President Barack Obama proposed a $215 million federal Precision Medicine Initiative with cancer as one of its priorities.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Rodney Edwin Shackelford, DO Po Box 746450, Atlanta, GA 30374-6450 Ph: (866) 401-3057 | Dr Rodney Edwin Shackelford, DO 2451 University Hospital Dr, Mobile, AL 36617-2300 Ph: (251) 471-7790 |
News Archive
Researchers at the University of Kentucky's College of Medicine have found that a class of antibiotics called aminoglycosides could be a promising treatment for frontotemporal dementia.
Obese men with prostate cancer are at higher risk for treatment failure after primary radiation therapy, according to a new study.
An Indiana University cancer researcher and her colleagues have identified genetic markers that may help determine who benefits from regular use of aspirin and other nonsteroidal anti-inflammatory drugs for lowering one's risk of developing colorectal cancer.
Cochlear Limited, the global leader in implantable hearing solutions, announced that the US Food and Drug Administration cleared the Cochlear Baha 4 Attract System for use in the United States. Cochlear is the only company to now offer patients a choice of either a magnetic or a direct bone conduction hearing solution.
Precision cancer medicine - diagnosis and treatment based on the genetic abnormalities of a specific tumor - is playing an ever-larger role in cancer care. The field got a boost earlier this year when President Barack Obama proposed a $215 million federal Precision Medicine Initiative with cancer as one of its priorities.
› Verified 8 days ago
Dr. Lloyd Gardner, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 5 Mobile Infirmary Cir, Mobile, AL 36607 Phone: 251-460-0326 Fax: 251-460-2846 | |
Dr. Lee Fucich, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 5 Mobile Infirmary Cir, Mobile, AL 36607 Phone: 251-460-0326 Fax: 251-460-2846 | |
Elizabeth A. Manci, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 1700 Center St, Pathology, Mobile, AL 36604 Phone: 251-415-1612 Fax: 251-415-1003 | |
Carole Boudreaux, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 2451 Fillingim St, Pathology, Mobile, AL 36617 Phone: 251-471-7790 Fax: 251-471-7715 | |
Jonathan Newsom, Pathology Medicare: Medicare Enrolled Practice Location: 2451 University Hospital Dr, Mobile, AL 36617 Phone: 251-470-9912 | |
Eugene Hart, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 2451 Fillingim St, Department Of Pathology, Mobile, AL 36617 Phone: 251-471-7026 |